You are here

Women's Imaging


A new study published in the January issue of the Journal of Ultrasound in Medicine has shown that a 3D power Doppler ultrasound can more accurately determine altered fetal growth restriction (FGR) in fetuses vulnerable to developing abnormal cerebral vascular flow patterns than a standard 2D Doppler ultrasound.  

Breast cancer mortality rates in the U.S. have decreased by roughly 50 percent from 2000 to 2012, according to a new stimulation modeling study released online Jan. 9 by JAMA.

A Children’s National Health System team has found velocity-selective arterial spin labeling (VSASL), an advanced MRI technology, can detect early signs of global placental perfusion in pregnancies complicated by fetal congenital heart disease (CHD).

The American Institute of Ultrasound in Medicine (AIUM) developed a task force to develop a standardized consensus-based curriculum and competency assessment tools for OB-GYN ultrasounds, with the aim they would be used in residency programs.

Researchers, investigating how community practices are following breast cancer screening guidelines, found that high-risk individuals, especially those with a family history of the disease, were not receiving additional MRI scans to help in early detection.


Recent Headlines

Breast cancer incidentally found in 17% of chest CT patients

Thirteen of 75 patients who had abnormal incidental findings in the breast after undergoing chest CT, or 17.3 percent, ended up indeed having breast cancer in a recent study, prompting the authors to recommend follow-up breast-specific imaging in all such cases.

New study to pit mammography vs. DNA blood test

Can a genomics blood test catch signature bits of DNA that break off of breast-cancer cells and float through the bloodstream? If so, can the test reliably confirm mammography findings—or possibly alert clinicians to the presence of a tumor even more quickly than imaging can?

Patients less likely to use DBT screening mammography due to financial responsibility

Patients are less likely to choose digital breast tomosynthesis screening mammography (DBTSM), despite more accurate results than traditional 2D mammography screening (2DSM), because of potential financial considerations, according to a new study published in the Journal of the American College of Radiology.

Nearly 90% of mammography sites satisfying quality inspectors

More than 87 percent of the 8,700 or so FDA-certified mammography facilities in the U.S. are in complete compliance with the Mammography Quality Standards Act (MQSA) of 1992. And, of those that have fallen short on any MQSA measure, fewer than 1 percent have a serious violation.

Accurate breast cancer risk prediction achieved with image conversion, AI-like classification

Computer scientists in the U.S. and China have demonstrated a mammographic image conversion method that incorporates optical-density features and combines with a computer-aided classification scheme to boost the accuracy of risk predictions for breast cancer.

Dense breast tissue may await 20-something women who drink spirits rather than beer, wine

Young women who drink spirits—i.e., “hard liquor”—may be more prone to developing dense breast tissue than their peers who either stick to beer and wine or don’t drink at all.

Mega trial looks to compare efficacy of 2D and 3D mammography

ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and the National Cancer Institute (NCI) are leading the Tomosynthesis Mammographic Imaging Screening Trial, the first randomized trial to compare 2D and 3D digital mammography screening.

Breast-care joint venture launches in Texas

Two large, Texas-based provider organizations have entered into a joint-venture agreement that, they say, will improve access to breast imaging and related services in and around Houston.

New BI-RADS guidelines may multiply dense-breast counts

Reviewing their group’s implementation of the fifth edition of the American College of Radiology’s BI-RADS Atlas, breast radiologists at the Medical University of South Carolina have observed considerable reader variability in determinations of which patients have dense breast tissue.

Older breast-cancer survivors evidence puzzling patterns in surveillance mammography

Despite known risks and unknown benefits, many older survivors of breast cancer with short life expectancy go for surveillance mammography every year. Meanwhile, relatively few with robust life expectancy don’t seem to bother. At the very least, the odd juxtaposition calls for guidelines to tailor care for both these older cancer-survivor subsets.